Antibody Affinity Maturation

Affinity maturation is one of the most applied strategies for monoclonal antibodies to enhance efficacy, reduce immunogenicity and improve potency. SanyouBio offers antibody affinity maturation services, which can improve affinity, blocking activity, species cross reactivity and developability.

According to the principle of in vivo affinity maturation, we adopt a variety of mutation strategies, and used phage display technology to construct a large-capacity mutation library to obtain antibodies with significantly improved affinity.

Service Highlights

1. Extreme enhancement of affinity activity

  • By applying advanced structure simulation and multiple mutagenesis strategies, the affinity of antibodies can be enhanced, and the average enhancement ranges from 5 to100 folds.

2. Comprehensive verification of eukaryotic expression

  • With mammalian cell expression system (CHO/HEK293), our platform can provide natural conformation-like and highly bioactive recombinant proteins. Moreover, comprehensive QC will be conducted to ensure the quality of the produced protein.

3. Unlimited competencies for various target types

  • Our SY-FLAM platform can serve for all kinds of targets, and can be customized for projects with high difficulty or special requirement. Representative targets: LAG3, IL- 23, CD47, Claudin18.2, etc.

4. Extensive experience project development

  • Our SY-FLAM platform has performed more than 180 affinity maturation projects. Our core R&D experts have more than 10 years of experience, and will offers the best service based on the requirements of the project.

5. Rapid and qualified delivery in 6 weeks

  • Our SY-FLAM platform can achieve a single round affinity maturation within 6 weeks. In coordination with comprehensive QC system, we are able to accomplish delivery with high efficiency and quality.

Popular articles

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more
Shanghai Model Organisms Jinshan R&D Base officially put into operation

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Learn more